Craig Bijou
Stock Analyst at B of A Securities
(3.78)
# 683
Out of 4,962 analysts
63
Total ratings
60%
Success rate
55.59%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Underperform | $18 → $9 | $8.61 | +4.53% | 2 | Jul 9, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $39.31 | +113.69% | 4 | Apr 25, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $127.55 | +9.76% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $14.53 | +17.00% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $61.38 | +58.03% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $14.27 | +26.14% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $108.79 | +33.28% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $88.16 | +16.83% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $55.23 | +53.90% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $74.59 | +15.30% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $73.48 | +29.29% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $16.05 | +124.30% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $7.52 | +498.40% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $3.72 | +3,125.81% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.27 | +469.26% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $15.36 | -15.36% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $14.50 | +189.66% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $468.44 | -50.90% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $390.88 | -41.16% | 4 | Jul 26, 2019 |
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $8.61
Upside: +4.53%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $39.31
Upside: +113.69%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $127.55
Upside: +9.76%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $14.53
Upside: +17.00%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $61.38
Upside: +58.03%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $14.27
Upside: +26.14%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $108.79
Upside: +33.28%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $88.16
Upside: +16.83%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $55.23
Upside: +53.90%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $74.59
Upside: +15.30%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $73.48
Upside: +29.29%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $16.05
Upside: +124.30%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $7.52
Upside: +498.40%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $3.72
Upside: +3,125.81%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $5.27
Upside: +469.26%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $15.36
Upside: -15.36%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $14.50
Upside: +189.66%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $468.44
Upside: -50.90%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $390.88
Upside: -41.16%